Top Featured Companies Dominating the Global Gastrointestinal Radiofrequency Ablation Systems Market
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ATRICURE, INC.
- Royal Philips
- Boston Scientific Corporation
- Johnson & Johnson
Browse Key Market Insights with Data Illustration:
In the News
- June 2020: Boston Scientific Corporation introduced DIRECTSENSE Technology, a device for tracking how radiofrequency (RF) energy is delivered during cardiac ablation procedures. Furthermore, the DIRECTSENSE Technology offers information on the impedance around the catheter tip to gauge the tissue's responsiveness to RF radiation.
- August 2022: Medtronic plc acquired Affera, Inc. to extend the first-ever cardiac mapping and navigation platform, which includes radiofrequency ablation solution, to the company's cardiac ablation product line. Further, this acquisition gives the company access to the Affera Prism-1 cardiac mapping and navigation platform, which is compatible with both Medtronic therapeutic catheters and a variety of competing technologies.